January 1, 2022 Journal article Open Access

Andrea Mussini; Eleonora Uriati; Paolo Bianchini; Alberto Diaspro; Luigi Cavanna; Stefania Abbruzzetti; Cristiano Viappiani

DataCite XML Export

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://www.openaccessrepository.it/record/112875</identifier>
  <creators>
    <creator>
      <creatorName>Andrea Mussini</creatorName>
    </creator>
    <creator>
      <creatorName>Eleonora Uriati</creatorName>
    </creator>
    <creator>
      <creatorName>Paolo Bianchini</creatorName>
    </creator>
    <creator>
      <creatorName>Alberto Diaspro</creatorName>
    </creator>
    <creator>
      <creatorName>Luigi Cavanna</creatorName>
    </creator>
    <creator>
      <creatorName>Stefania Abbruzzetti</creatorName>
    </creator>
    <creator>
      <creatorName>Cristiano Viappiani</creatorName>
    </creator>
  </creators>
  <titles>
    <title>Targeted photoimmunotherapy for cancer</title>
  </titles>
  <publisher>INFN Open Access Repository</publisher>
  <publicationYear>2022</publicationYear>
  <subjects>
    <subject>Cellular and Molecular Neuroscience</subject>
    <subject>General Biochemistry, Genetics and Molecular Biology</subject>
    <subject>General Medicine</subject>
  </subjects>
  <dates>
    <date dateType="Issued">2022-01-01</date>
  </dates>
  <language>en</language>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://www.openaccessrepository.it/record/112875</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1515/bmc-2022-0010</relatedIdentifier>
    <relatedIdentifier relatedIdentifierType="URL" relationType="IsPartOf">https://www.openaccessrepository.it/communities/itmirror</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">AbstractPhotodynamic therapy (PDT) is a clinically approved procedure that can exert a curative action against malignant cells. The treatment implies the administration of a photoactive molecular species that, upon absorption of visible or near infrared light, sensitizes the formation of reactive oxygen species. These species are cytotoxic and lead to tumor cell death, damage vasculature, and induce inflammation. Clinical investigations demonstrated that PDT is curative and does not compromise other treatment options. One of the major limitations of the original method was the low selectivity of the photoactive compounds for malignant over healthy tissues. The development of conjugates with antibodies has endowed photosensitizing molecules with targeting capability, so that the compounds are delivered with unprecedented precision to the site of action. Given their fluorescence emission capability, these supramolecular species are intrinsically theranostic agents.</description>
  </descriptions>
</resource>